$EXAM (ExamWorks Group, Inc.)

$EXAM {{ '2016-01-19T22:41:51+0000' | timeago}} • Announcement

IME services provider $EXAM said that it has acquired Advanced Medical Reviews, a national peer review provider based in Santa Monica, CA, for an all cash purchase price of $30MM. $EXAM funded the acquisition with cash on hand and borrowings under its existing revolving credit facility.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$TBPH {{ '2017-07-20T12:32:48+0000' | timeago}} • Announcement

$TBPH and $MYL announced positive results from a 12-month Phase 3 safety study of revefenacin in patients with chronic obstructive pulmonary disease (COPD). The study of 1,055 patients with COPD demonstrated that revefenacin was generally well-tolerated, and no new safety issues were identified.

$AKRX {{ '2017-07-19T21:41:28+0000' | timeago}} • Announcement

Specialty generic pharmaceutical company $AKRX said that its shareholders have voted to approve the merger for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA. The companies expect the acquisition to close by early 2018.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$MYL {{ '2017-07-14T12:05:52+0000' | timeago}} • Announcement

Pharma firm $MYL said the FDA Oncologic Drugs Advisory Committee has recommended approval of the biosimilar trastuzumab developed by Mylan along with India-based Biocon Ltd. for  treatment of breast cancer. The committee determined no clinically meaningful differences exist between the biosimilar product and cancer drug Herceptin.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$PRSC {{ '2017-07-07T15:47:58+0000' | timeago}} • Announcement

$PRSC has appointed Jeff Felton as the CEO of its subsidiary LogistiCare Solutions, LLC, effective July 10, 2017. He most recently served as President of McKesson Connected Care and Analytics and he has also worked at Cardinal Health, Baxter Healthcare and Procter and Gamble.

$USPH {{ '2017-06-29T19:00:45+0000' | timeago}} • Webcast

$USPH estimates its corporate office costs, as a percentage of revenue, will be in the upper 8% to lower 9% range this year. The company said its recently adopted accounting standard and a change in the value of restricted share grants resulted in tax credit in 1Q17. The current focus is on acquisition-related opportunities to sustain growth.

$USPH {{ '2017-06-29T18:56:30+0000' | timeago}} • Webcast

$USPH expects its newly-launched analytics tool to bear good fruit as the year progresses. The company intends to continue consolidation of its smaller partnerships. The visits per clinic per day progressed sequentially in 1Q17 and has continued to progress well.

$ABT {{ '2017-06-29T17:53:11+0000' | timeago}} • Announcement

$ABT announced the Health Canada license of its FreeStyle Libre Flash Glucose Monitoring System, a glucose sensing technology for adults with diabetes. This system eliminates the need for routine finger sticks or finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days.

$WBA {{ '2017-06-29T14:01:47+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. $WBA expects the new transaction to be modestly accretive to its adjusted EPS in the first full year after the initial closing of the new transaction, and expects to realize synergies from the new transaction in excess of $400MM.

$WBA {{ '2017-06-29T14:01:00+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. This new agreement replaces the previous merger agreement with Rite Aid, announced in October 2015 and amended in January 2017. The initial closing of the new transaction is expected to occur within the next six months.

$WBA {{ '2017-06-29T14:00:00+0000' | timeago}} • Announcement

$WBA agreed to buy 2,186 stores, three distribution centers and related inventory from $RAD. The consideration for the transaction will be $5.175Bil in cash, the assumption by $WBA of the related real estate leases and the grant of an option to $RAD to become a member of $WBA's group purchasing organization, Walgreens Boots Alliance Development.

$WBA {{ '2017-06-29T13:35:36+0000' | timeago}} • Webcast

$WBA said that on the $RAD agreement, while the company is assuming a real-estate obligation, it is not assuming any debt. Additionally, $WBA is expecting the deal to give significant cash tax benefit, as it tax amortizes the intangible assets it acquires from $RAD.

$USPH {{ '2017-06-29T12:50:35+0000' | timeago}} • Announcement

$USPH's revenue for 1Q17 increased 12.3% from last year. This was primarily due to a 10.1% rise in net patient revenues from physical therapy operations, higher revenues from management contracts due to rise in managed facilities and one month of revenues from workforce performance solutions business acquired in March 2017.

Recent Transcripts

USPH (US Physical Therapy Inc.)
Thursday, June 29 2017 - 2:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
PMC (PharMerica Corporation)
Wednesday, May 10 2017 - 2:00pm
MYL (Mylan N.V.)
Wednesday, May 10 2017 - 2:00pm
PRSC (Providence Service Corp.)
Wednesday, May 10 2017 - 12:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
PETS (PetMed Express, Inc.)
Monday, May 8 2017 - 12:30pm
LHCG (LHC Group, Inc.)
Thursday, May 4 2017 - 3:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
CVS (CVS Health Corporation)
Tuesday, May 2 2017 - 12:30pm
CHE (Chemed Corp.)
Thursday, April 27 2017 - 2:00pm
ABT (Abbott Laboratories)
Wednesday, April 19 2017 - 1:00pm
USPH (US Physical Therapy Inc.)
Thursday, March 16 2017 - 2:30pm
PRSC (Providence Service Corp.)
Friday, March 10 2017 - 1:00pm
LHCG (LHC Group, Inc.)
Thursday, March 9 2017 - 4:00pm
KTWO (K2M Group Holdings, Inc.)
Monday, March 6 2017 - 10:00pm
AKRX (Akorn, Inc.)
Wednesday, March 1 2017 - 3:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, February 28 2017 - 10:00pm

AlphaGraphics you may like